IXALTIS
Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs. The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik and Professors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders. IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.
IXALTIS
Industry:
Biopharma Biotechnology Health Care Medical Medical Device Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Toulouse, Midi-Pyrenees, France
Country:
France
Website Url:
http://www.ixaltis.com
Total Employee:
11+
Status:
Active
Contact:
+33 (0)4 57 26 00 76
Email Addresses:
[email protected]
Total Funding:
8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins IPv6 Google Apps For Business Google Maps
Current Employees Featured
Founder
Investors List
IXO Private Equity
IXO Private Equity investment in Venture Round - Ixaltis
Principia SGR
Principia SGR investment in Venture Round - Ixaltis
Pierre Olivier Goineau
Pierre Olivier Goineau investment in Venture Round - Ixaltis
IRDI
IRDI investment in Venture Round - Ixaltis
Sofimac Investment Managers
Sofimac Investment Managers investment in Venture Round - Ixaltis
Official Site Inspections
http://www.ixaltis.com
- Host name: gpaas2.dc0.gandi.net
- IP address: 217.70.180.132
- Location: Paris France
- Latitude: 48.8543
- Longitude: 2.3527
- Timezone: Europe/Paris
- Postal: 75000
More informations about "Ixaltis"
About us – IXALTIS
IXALTIS is start-up pharmaceutical company specialized in genitourinary and renal diseases. The company was born out of the combined expertise of scientists specialized in urology, … See details»
Ixaltis - Crunchbase Company Profile & Funding
Ixaltis is a pharmaceutical company that develops therapeutics to treat … See details»
Ixaltis 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Ixaltis. Use the PitchBook Platform to explore the full profile. See details»
IXALTIS Company Profile - Office Locations, Competitors ... - Craft
IXALTIS has 5 employees across 2 locations and $8.9 m in total funding,. See insights on IXALTIS including office locations, competitors, revenue, financials, executives, subsidiaries … See details»
Ixaltis - Overview, News & Similar companies | ZoomInfo.com
View Ixaltis (www.ixaltis.com) location in Auvergne-Rhone-Alpes, France , revenue, industry and description. Find related and similar companies as well as employees by title and much more. See details»
Ixaltis - VentureRadar
IXALTIS is start-up pharmaceutical company specialized in genitourinary and renal diseases. The company was born out of the combined expertise of scientists specialized in urology, … See details»
IXALTIS SA - LinkedIn
IXALTIS is a specialty pharmaceutical company developing proprietary therapeutics to treat genitourinary (GU) disorders with unsatisfied medical need. The company was born from the … See details»
IXALTIS
Become a leading developer of innovative pharmaceutical products for treating disorders of the urogenital tract. Development 3 clinical compounds licensed from Sanofi kick start the … See details»
IXALTIS Company Profile | TOULOUSE, OCCITANIE, France
Find company research, competitor information, contact details & financial data for IXALTIS of TOULOUSE, OCCITANIE. Get the latest business insights from Dun & Bradstreet. See details»
IXALTIS SA Information - RocketReach
IXALTIS SA is a Biotechnology Research, Manufacturing General, and Biopharma company located in Toulouse, Occitanie with $7.3 million in revenue and 2 employees. Find top … See details»
Team – IXALTIS
Dr. Nigel Roome MSc, PhD Non clinical toxicology expertBusiness development team See details»
IXALTIS Company Profile | ARCHAMPS, AUVERGNE RHONE ALPES, …
Find company research, competitor information, contact details & financial data for IXALTIS of ARCHAMPS, AUVERGNE RHONE ALPES. Get the latest business insights from Dun & … See details»
Ixaltis gets funds to repurpose drug | C&EN Global Enterprise
Jun 13, 2016 Ixaltis, a start-up company focused on urogenital disorders, has raised $9 million in its first funding round. The French firm’s pipeline consists of three compounds licensed from … See details»
Ixaltis - Contacts, Employees, Board Members, Advisors & Alumni
Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs. See details»
Press – IXALTIS
Press Release, Ixaltis – Positive Results from phase 2 studies for Litoxetine, October 2019 Read More In Press 14 Mai 2019 See details»
IXALTIS stengthens its portfolio by entering into an agreement …
Oct 3, 2017 Ixaltis, the start-up specialized in developing treatments for urogenital disorders, and Xigen, a privately-owned biopharmaceutical company that specializes in the development of … See details»
Board of Directors – IXALTIS
Christian Chavy Chairman of the BoardRoberto Gradnik CEO See details»
Ixaltis - Funding, Financials, Valuation & Investors - Crunchbase
Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs. See details»
Contact – IXALTIS
Name* E-mail* Company Subjet* Message*Contact Us See details»
Pipeline – IXALTIS
IXALTIS has already in-licensed, with an exclusive worldwide deal, three molecules from SANOFI, Litoxetine, IXA-002, and IXA-003. See details»